Arca Biopharma slates third quarter for COVID treatment trial results
WESTMINSTER — ARCA Biopharma Inc. (Nasdaq: ARCA) posted far higher expenses in 2020 as it pivoted to COVID-19 treatment research, […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Climate ‘game-changer’
High atop Table Mesa in southwest Boulder, visitors to the National Center for Atmospheric Research enjoy more than just a…
Climate ‘game-changer’
High atop Table Mesa in southwest Boulder, visitors to the National Center for Atmospheric Research see more than just a…
Arca Biopharma: Losses lower, no M&A decision in first quarter
BOULDER — At the end of the first quarter of 2023, a period in which Arca Biopharma Inc. (Nasdaq: ABIO)…
Economy sends conflicting signals
First the bad news: Interest rates are soaring. Inflation continues to climb. Gross domestic product is declining nationally and in…